Find a Trial
Trial Summary
| Protocol No. | PHO-COG-AAML1831 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Batra, Sandeep | ||
| Scope | National | ||
| Phase | Phase III | ||
| Age Group | Adults and Children | ||
| Title | AAML1831, A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations. | ||
| Applicable Disease Sites | Leukemia, other | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||